SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001102624-16-003572
Filing Date
2016-11-03
Accepted
2016-11-03 08:05:22
Documents
3
Period of Report
2016-11-03

Document Format Files

Seq Description Document Type Size
1 ACASTI PHARMA INC. 6-K acasti6k.htm 6-K 17843
2 EXHIBIT 99.1 exh99_1.htm EX-99.1 10973
3 image00001.jpg GRAPHIC 8407
  Complete submission text file 0001102624-16-003572.txt   41522
Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3
Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 161970213
SIC: 2834 Pharmaceutical Preparations